Laddar...
Advances in Immunotherapy for Glioblastoma Multiforme
Glioblastoma multiforme (GBM) is the most common primary malignant brain tumor in adults. Patients with GBM have poor outcomes, even with the current gold-standard first-line treatment: maximal safe resection combined with radiotherapy and temozolomide chemotherapy. Accumulating evidence suggests th...
Sparad:
| I publikationen: | J Immunol Res |
|---|---|
| Huvudupphovsmän: | , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Hindawi Publishing Corporation
2017
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5337363/ https://ncbi.nlm.nih.gov/pubmed/28299344 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/3597613 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|